Medtronic (MDT) Inks Deal To Focus On Value-Based Healthcare

 | Dec 16, 2019 10:00PM ET

Medtronic plc (NYSE:MDT) recently entered into a five-year collaborative agreement with health care organization ChristianaCare for the improvement of patient outcome in Delaware and its surroundings. Financial terms of the deal have been kept under wraps.

Per Medtronic, this initiative will also reduce healthcare costs.

The Deal at a Glance

Under this five-year contract, the companies will focus on implementing value-based healthcare initiatives over fee-for-service system as according to them, value-based care is the key to achieving optimal health at accessible and affordable price.

This effort will help ChristianaCare apply appropriate medical technologies and therapies to the targeted patients. With shared financial accountability between ChristianaCare and Medtronic, this will enhance health results at lower costs.

The first initiative of this joint effort targets to address opioid-induced ventilatory impairment (OIVI). OIVI occurs when opioids used for pain management, hinder the central drive to breathe and may cause the patient to go absolute breathless unless there is any life-saving measure to redress the problem. Under this initiative, patients at high risk of OIVI will be identified and administered with continuous monitoring technology to track breathing and help alert the care team about any abnormal trends.